NXF2 and acute leukemia: Treatment of multiple human acute leukemia cell lines (Kasumi-1, U937, NB4, THP-1, Jurkat, and Molt-4) with decitabine activated the expression of the CTA nuclear RNA export factor 2 (NXF2).